CorMedix’s (CRMD) Outperform Rating Reiterated at Royal Bank Of Canada
Royal Bank Of Canada reissued their outperform rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. Royal Bank Of Canada currently has a $17.00 price objective on the stock, up from their previous price objective of $13.00. CRMD has been the subject of several […]
Royal Bank Of Canada reissued their outperform rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. Royal Bank Of Canada currently has a $17.00 price objective on the stock, up from their previous price objective of $13.00. CRMD has been the subject of several […]
